https://www.selleckchem.com/pr....oducts/caspofungin-a
RESULTS During the study period, 1,303 patients received primary THA. 338 (25.9%) were eligible for day-surgery, but 17 (5%) declined; the day-surgery series thus comprised 321 patients (24.6%) 166 men, 155 women; mean age, 61.2±9.7 years. Same-day discharge was not possible for 14 patients (4.5%) 9 due to persistent faintness, 2 to intraoperative femoral fracture, 1 to organizational issues, 1 to an uncomplicated fall, and 1 to hemoglobinemia less then 11g/100ml in a coronary patient. There were no readmissions during week
Beğen
Yorum Yap
Paylaş
